In conclusion, this meta-analysis showed that an increased risk of childhood acute leukemia is associated with the null polymorphism of GSTM1. It is necessary to conduct large sample studies using standardized unbiased genotyping methods, homogeneous patients with childhood acute leukemia and well matched controls. This evidence concerns the gene GSTM1 and acute leukemia.